The Children's Hospital at Westmead is a children's hospital in Western Sydney. The hospital was founded in 1880 as "The Sydney Hospital for Sick Children".

There are 340 beds in Sydney Children's Hospital.

During the past decade, Sydney Children's Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sydney Children's Hospital" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Bayer" with 2 trials sponsored, "Murdoch Childrens Research Institute" with 2 trials sponsored, "Sydney Children's Hospitals Network" with 2 trials sponsored and "The University of Queensland" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sydney Children's Hospital" #1 collaborator was "Royal Children's Hospital" with 2 trials as a collaborator, "Sydney Children's Hospitals Network" with 2 trials as a collaborator, "Belite Bio, Inc" with 1 trials as a collaborator, "Children's Cancer Institute Australia" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Sydney Children's Hospital" are "Brain Diseases" (2 trials), "Central Nervous System Diseases" (2 trials), "Cystic Fibrosis" (2 trials), "Disease" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Sydney Children's Hospital" in a lesser frequency.

Most popular intervention types in "Sydney Children's Hospital" are "Drug" (24 trials), "Other" (4 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (3 trials), "Ramucirumab" (2 trials), "XEN496" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sydney Children's Hospital" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Sydney Children's Hospital". undefined are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sydney Children's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sydney Children's Hospital, 10 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".